1. Citigroup currently has a “buy” rating on Leidos stock.
2. Leidos stock has a 52-week low of $31.76 and a 52-week high of $47.18.
3. The stock has a 50-day moving average of $41, according to the report. The stock’s 200-day moving average is $42.
4. Leidos has a market cap of $3.03 billion.
5. Jefferies Group set the company’s price target at $42. Credit Suisse set the price target at $41.
More articles on finance issues:
The finance function of tomorrow: 5 takeaways
Payment disruption in healthcare: Which factors will have a high impact?
How health systems can take control of purchased services
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
